🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,254 results for “First” Clear

  1. Cytarabine

    First Tracks Biotherapeutics

    Leukemia

    phase 3 small molecule active

    1 trial

  2. Decitabine

    First Tracks Biotherapeutics

    Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  3. Decitabine

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia, Adult

    phase 3 small molecule active

    1 trial

  4. Decitabine

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  5. Decitabine plus HAAG regimen

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  6. Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion, Midazolam Lek 1 mg/ml raztopina za injiciranje/infundiranje

    Tour Hekla

    Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care:

    phase 3 small molecule active

    1 trial

  7. Dipyridamole 50mg tid

    First Tracks Biotherapeutics

    Restless Leg Syndrome Due to Uraemia

    phase 3 small molecule active

    1 trial

  8. Eltrombopag 25 MG Oral Tablet

    First Tracks Biotherapeutics

    Stem Cell Transplant Complications

    phase 3 small molecule completed

    1 trial

  9. Endostar

    First Tracks Biotherapeutics

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  10. Erythropoietin

    First Tracks Biotherapeutics

    Premature Infants

    phase 3 small molecule active

    1 trial

  11. EstroTep 500 MBq/mL, solution injectable

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Women with ER+ HER2- metastatic breast cancer who progressed on first line therapy with CDK4/6 inhibitor and aromatase inhibitor

    phase 3 small molecule active

    1 trial

  12. Etoposide

    First Tracks Biotherapeutics

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  13. Etoposide

    First Tracks Biotherapeutics

    Non-Hodgkin's Lymphoma

    phase 3 small molecule active

    1 trial

  14. Fosaprepitant

    First Tracks Biotherapeutics

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  15. G-SCF

    First Tracks Biotherapeutics

    Granulocyte Colony-stimulating Factor

    phase 3 small molecule active

    1 trial

  16. Gefarnate

    First Tracks Biotherapeutics

    Coronary Artery Disease

    phase 3 small molecule active

    1 trial

  17. Gilteritinib

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

  18. Gonal-F

    First Tracks Biotherapeutics

    Anovulation

    phase 3 mab completed

    1 trial

  19. HVA

    First Tracks Biotherapeutics

    Newly Diagnosed Acute Myeloid Leukemia With High Risk

    phase 3 small molecule active

    1 trial

  20. Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

    First Tracks Biotherapeutics

    Gastric Cancer

    phase 3 other active

    1 trial

  21. IAC regimen

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  22. Induction Chemotherapy

    First Tracks Biotherapeutics

    Locally Advanced Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  23. Infrared ray heat treatment

    First Tracks Biotherapeutics

    Liver Cirrhosis

    phase 3 other active

    1 trial

  24. Intermediate-dose Cytarabine in Combination with Venetoclax

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources